Manchester Capital Management LLC Has $1.57 Million Holdings in UnitedHealth Group Incorporated $UNH

Manchester Capital Management LLC reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 11.2% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,036 shares of the healthcare conglomerate’s stock after selling 638 shares during the period. Manchester Capital Management LLC’s holdings in UnitedHealth Group were worth $1,571,000 at the end of the most recent quarter.

Other institutional investors have also made changes to their positions in the company. Verity & Verity LLC lifted its stake in shares of UnitedHealth Group by 16.6% in the second quarter. Verity & Verity LLC now owns 2,576 shares of the healthcare conglomerate’s stock worth $804,000 after buying an additional 367 shares during the last quarter. Laurel Wealth Advisors LLC lifted its position in UnitedHealth Group by 25,471.4% during the 2nd quarter. Laurel Wealth Advisors LLC now owns 109,190 shares of the healthcare conglomerate’s stock worth $34,064,000 after acquiring an additional 108,763 shares during the last quarter. XTX Topco Ltd acquired a new stake in shares of UnitedHealth Group in the second quarter valued at about $2,993,000. South Plains Financial Inc. boosted its stake in UnitedHealth Group by 4.0% during the 2nd quarter. South Plains Financial Inc. now owns 2,411 shares of the healthcare conglomerate’s stock valued at $752,000 after purchasing an additional 92 shares during the period. Finally, Insigneo Advisory Services LLC increased its position in UnitedHealth Group by 35.9% in the 2nd quarter. Insigneo Advisory Services LLC now owns 8,037 shares of the healthcare conglomerate’s stock worth $2,507,000 after buying an additional 2,124 shares during the period. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $318.89 on Tuesday. The stock has a fifty day moving average price of $344.10 and a two-hundred day moving average price of $315.39. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.82 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $622.83. The firm has a market capitalization of $288.86 billion, a P/E ratio of 16.64, a P/E/G ratio of 2.28 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.87 by $0.05. The firm had revenue of $113.16 billion during the quarter, compared to the consensus estimate of $113.19 billion. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The firm’s quarterly revenue was up 12.2% on a year-over-year basis. During the same period last year, the firm posted $7.15 EPS. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th will be given a $2.21 dividend. The ex-dividend date is Monday, December 8th. This represents a $8.84 annualized dividend and a yield of 2.8%. UnitedHealth Group’s payout ratio is presently 46.14%.

Analysts Set New Price Targets

A number of brokerages recently issued reports on UNH. Oppenheimer dropped their target price on shares of UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a research report on Wednesday, July 30th. Sanford C. Bernstein increased their target price on shares of UnitedHealth Group from $433.00 to $440.00 and gave the company an “outperform” rating in a research note on Thursday, October 30th. Zacks Research raised UnitedHealth Group from a “strong sell” rating to a “hold” rating in a report on Monday, October 6th. Weiss Ratings upgraded UnitedHealth Group from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, October 24th. Finally, Bank of America lifted their price target on shares of UnitedHealth Group from $350.00 to $390.00 and gave the stock a “neutral” rating in a research note on Wednesday, October 8th. Eighteen analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $397.12.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.